Skip to main content
OpenTrials
Completed

NCT Number: NCT02449486

Ropivacaine After Sternotomy

Continuous ropivacaine infusion to sternotomy wound after coronary artery bypass grafting (CABG) or heart valve surgery to diminish postoperative pain.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Postoperative Pain Neurologic Manifestations Pain Pain, Postoperative Pathologic Processes Pathological Conditions, Signs and Symptoms Postoperative Complications Signs and Symptoms

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Kuopio University hospital

Kuopio, FI70029, Finland

About this study

A multiporous catheter will be introduced into sternotomy wound to CABG or heart valve surgery patients and continuous ropivacaine infusion 4 ml/h will be started immediately after surgery. Ropivacaine infusion will be administered during 48 postoperative hours. All patients receive patient controlled analgesia (PCA) oxycodone after extubation in the PACU. All patients receive a standardized anesthesia during surgery.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Elective CABG or heart valve surgery patients

Exclusion criteria

  • Psychic disorders
  • Sleep apnea syndrome
  • Diabetes mellitus (insulin dependent)
  • Obesity, body mass index (BMI) ≥ 35
  • Cardiac insufficiency, ejection fraction (EF) ≤ 30

Treatment and study plan

Ropivacaine

Drug

Primary outcomes

  1. Postoperative oxycodone consumption

    Time frame: 48 postoperative hours

    postoperative PCA administered oxycodone

Secondary outcomes

  1. Pain measured with Visual Analog Scale

    Time frame: 48 postoperative hours

    pain measured with VAS at rest and on movement

Sponsors and collaborators

Lead sponsor

Kuopio University Hospital

Other

Registry information

Official study title

Ropivacaine Infusion to Alleviate Postoperative Pain After Cardiac Surgery

Acronym: NAROSYD

Important dates

Study start
2014
Primary completion
2017
Study completion
2017
First posted
May 20, 2015
Registry last updated
Apr 24, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.